Cancer remains a formidable global health challenge affecting millions of lives annually. For decades, conventional cancer treatments used a one-size-fits-all approach, overlooking the intricate genetic variations that drive tumors. The emergence of cancer genomics has ushered in a new era of
No takes yet. Share an insight, caveat, or question.
Yuki Katsuya (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: